Your browser doesn't support javascript.
loading
Hyperbilirubinemia and rapid fatal hepatic failure in severe combined immunodeficiency caused by adenosine deaminase deficiency (ADA-SCID).
Kühl, J S; Schwarz, K; Münch, A; Schmugge, M; Pekrun, A; Meisel, C; Wahn, V; Ebell, W; von Bernuth, H.
Afiliação
  • Kühl JS; University Hospital Berlin, Department for Pediatric Hematology and Oncology, Berlin, Germany.
Klin Padiatr ; 223(2): 85-9, 2011 Mar.
Article em En | MEDLINE | ID: mdl-21271505
ABSTRACT
Adenosin deaminase (ADA) deficiency is the cause for Severe Combined Immunodeficiency (SCID) in about 15% of patients with SCID, often presenting as T (-)B (-)NK (-)SCID. Treatment options for ADA-SCID are enzyme replacement, bone marrow transplantation or gene therapy. We here describe the first patient with ADA-SCID and fatal hepatic failure despite bone marrow transplantation from a 10/10 HLA identical related donor. As patients with ADA-SCID may be at yet underestimated increased risk for rapid hepatic failure we speculate whether hepatitis in ADA-SCID should lead to the immediate treatment with enzyme replacement by pegylated ADA.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Falência Hepática / Hiperbilirrubinemia Neonatal Tipo de estudo: Diagnostic_studies Idioma: En Revista: Klin Padiatr Ano de publicação: 2011 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Falência Hepática / Hiperbilirrubinemia Neonatal Tipo de estudo: Diagnostic_studies Idioma: En Revista: Klin Padiatr Ano de publicação: 2011 Tipo de documento: Article País de afiliação: Alemanha
...